The Centers for Medicare & Medicaid Services issued the 2027 Quality Payment Program final rule on Nov. 4, 2026. The updated policies will take effect Jan. 1, 2027. Key changes for sleep medicine are analyzed below.
Transition from traditional Merit-based Incentive Payment System (MIPS) to MIPS Value Pathways (MVPs)
CMS modified its proposal and will sunset traditional MIPS after the 2030 performance period/2032 MIPS payment year. Beginning with the 2031 performance period/2033 MIPS payment year, MIPS-eligible clinicians must report an MVP unless they are eligible to report the Alternative Payment Model (APM) Performance Pathway (APP). This adds two transition years beyond the proposed 2028 sunset and is responsive to AASM’s request for a deliberate transition supported by mature, specialty-relevant MVPs, reliable benchmarks, and adequate reporting infrastructure.
- Virtual groups may begin reporting MVPs in the 2029 performance period.
- Practices should use the additional transition time to identify an appropriate MVP, map workflows, confirm measure applicability, and prepare subgroup-level data collection where needed.
Impact on sleep medicine professionals and facilities
The delayed transition gives sleep medicine practices additional time to prepare for mandatory MVP participation. Practices should use this period to identify the MVP most applicable to their patient population, evaluate whether available quality measures reflect sleep medicine care, and determine whether their electronic health record (EHR), registry, or reporting vendor can support MVP reporting. Larger practices may also need to evaluate subgroup reporting workflows. The transition is especially important for independent sleep practices that may have limited administrative or health information technology (IT) resources.
Quality performance category
CMS finalized 180 quality measures for the 2027 performance period, excluding Qualified Clinical Data Registry (QCDR) measures that are approved outside rulemaking. The inventory reflects:
- Ten new measures available for 2027, including the conversion of current QCDR measures to MIPS clinical quality measures; one additional prevention and chronic disease measure is delayed until 2028.
- Twenty removed measures
- Forty-three existing measures with substantive revisions
The data completeness threshold remains 75% for the 2027 and 2028 performance periods.
Impact on sleep medicine professionals and facilities
With 20 measures removed and 43 substantively revised, sleep medicine practices should not assume that their existing MIPS quality measure set can continue unchanged in 2027. Practices should review the finalized measure inventory before the performance year, confirm that their selected measures remain available and applicable, and update EHR templates, registry mappings, documentation workflows, and staff education where measure specifications have changed. The continued 75% data-completeness threshold also makes consistent capture of eligible patients throughout the year important.
New MIPS core measure requirement
CMS removed the requirement to report an outcome measure, or a high-priority measure when an outcome measure is unavailable, and replaced it with a MIPS core measure requirement. CMS designated 78 measures as MIPS core measures.
- Traditional MIPS: Report one core measure among the six required quality measures.
- MVP reporting: Report one core measure designated for the selected MVP among the four required quality measures.
- If no core measure is applicable, the clinician or reporting entity must attest to that fact and report another measure instead.
- Small practices are exempt from the core measure requirement and the attestation process.
A nonexempt clinician or entity that neither reports a core measure nor submits the required attestation will receive 0 out of 10 points for one required quality measure. Topped-out core measures will not be subject to the seven-point cap and may earn up to 10 points under the defined benchmark methodology.
Impact on sleep medicine professionals and facilities
The new core measure requirement may require practices to reconsider which measures they select for MIPS or MVP reporting. Sleep medicine clinicians and facilities should determine early whether an applicable core measure exists and incorporate it into clinical documentation and reporting workflows. When no core measure applies, practices should ensure they complete the required attestation rather than simply omitting a core measure, because failure to report or attest can result in zero points for one required quality measure. Small practices are exempt from this requirement.
Updates to MVPs
CMS finalized 30 MVPs for 2027. The three new MVPs are:
- Diabetic disease
- Hypertension
- Hospitalist
CMS also modified all 27 existing MVPs to identify core measures, add or remove measures and activities, address maintenance requests, and broaden relevant clinical concepts. The Rehabilitative Support for Musculoskeletal Care MVP was renamed the Rehabilitative Support MVP.
For MVP reporting, clinicians select four quality measures, including one applicable core measure, and attest to one improvement activity. CMS calculates the cost and population-health measures from administrative claims.
Impact on sleep medicine professionals and facilities
Sleep medicine practices should begin evaluating MVP participation as part of their longer-term reporting strategy. Of relevance, the Pulmonology Care MVP and Quality Care for the Treatment of Ear, Nose, and Throat Disorders MVP include AASM quality measures Q277 and/or Q279. This creates an opportunity for some sleep clinicians, particularly those whose scope overlaps pulmonology or ear, nose, and throat (ENT) care, to report measures that are more closely aligned with their clinical practice. Practices should nevertheless review the complete MVP measure set before selecting a pathway because participation requires four quality measures, including an applicable core measure, as well as an improvement activity.
Cost performance category
CMS did not add or remove cost measures for the 2027 performance period. Cost continues to be calculated by CMS from administrative claims. For MVP participants, scoring is based only on the cost measures included in the selected MVP, subject to case minimums and other scoring rules.
Impact on sleep medicine professionals and facilities
Although CMS did not add or remove cost measures for 2027, sleep medicine clinicians should continue monitoring how Medicare services attributed to them affect cost performance. Because CMS calculates cost from claims rather than clinician-submitted data, billing, referral patterns, care coordination, and utilization occurring across a patient’s episode of care can influence performance without creating an additional reporting task for the practice. For MVP participants, the cost measures included in the selected MVP will be particularly important when evaluating which pathway best fits the practice.
Improvement activities performance category
For MVP reporting, clinicians, groups, and subgroups must attest to one improvement activity regardless of special status. Practices may continue to use the patient-centered medical home accreditation activity when applicable. Members should select an activity that fits routine sleep medicine workflows and retain supporting documentation for the applicable performance period.
Impact on sleep medicine professionals and facilities
MVP participants must attest to one improvement activity, making it important for sleep practices to select an activity that can be integrated into existing quality-improvement work rather than creating a separate administrative process. Activities involving care coordination, patient engagement, health information exchange, or recognized patient-centered medical home participation may complement existing sleep medicine workflows. Practices should also maintain documentation demonstrating completion of the activity during the performance period.
Promoting Interoperability and digital quality reporting
CMS finalized the following Promoting Interoperability changes:
- The security risk analysis measure is removed for the 2027 performance period.
- Electronic prior authorization is optional and eligible for bonus points in 2027; it becomes required in 2028.
- A new electronic prior authorization for prescription drugs measure becomes required in 2028.
- The Office of the National Coordinator for Health Information Technology (ONC) direct review and optional ONC-authorized certification body surveillance attestations are removed beginning with the 2026 performance period.
The final rule does not establish a 2027 Fast Healthcare Interoperability Resources (FHIR)-based digital quality reporting mandate. The AASM’s comments on phased implementation, vendor readiness, technical assistance, alternative reporting pathways, and protection for small and independent practices remain important for future rulemaking and implementation work.
Impact on sleep medicine professionals and facilities
The absence of a 2027 FHIR-based digital quality reporting mandate gives sleep practices additional time to assess their technology readiness. However, practices should continue preparing for increased electronic reporting and interoperability requirements. Electronic prior authorization is optional for bonus points in 2027 but becomes required in 2028, making 2027 an important implementation year for practices to work with EHR vendors, clearinghouses, pharmacies, and payers to test electronic prior-authorization workflows. This may be particularly relevant to sleep medicine services involving medications, testing, positive airway pressure (PAP) therapy, and other treatments that routinely encounter payer authorization requirements.
MIPS payment adjustments
The performance threshold remains 75 points for the 2027 and 2028 performance periods. For 2027 performance/2029 payment:
- Below 75 points: negative payment adjustment, up to -9%.
- Exactly 75 points: neutral payment adjustment.
- Above 75 points: positive adjustment, subject to statutory budget neutrality.
CMS did not change the performance-category weights for 2027.
Impact on sleep medicine professionals and facilities
The financial stakes remain significant for sleep medicine clinicians participating in MIPS. Performance below the 75-point threshold for the 2027 performance year can result in a Medicare payment adjustment of up to -9% in 2029, while scores above 75 may generate a positive adjustment. Practices should therefore monitor performance throughout 2027 rather than waiting until the end of the performance period to identify gaps in quality reporting, improvement activities, interoperability, or other applicable categories.
Advanced Alternative Payment Models
CMS will determine qualifying APM participant and partial qualifying participant (QP) status at the taxpayer identification number/national provider identifier (TIN/NPI) level rather than solely at the NPI level, directing incentives to TINs that actively participate in Advanced APMs. CMS also updated the QP and partial QP thresholds for the 2026 performance period/2028 payment year under the Consolidated Appropriations Act, 2026. The AASM’s broader request for more accessible and specialty-relevant Advanced APM opportunities remains an important advocacy priority for sleep medicine practices.
Impact on sleep medicine professionals and facilities
The shift toward determining qualifying APM participant and partial QP status at the TIN/NPI level may be particularly important for sleep physicians working within multispecialty organizations or health systems. Participation decisions made at the organizational level could affect individual sleep clinicians’ QPP status and incentives. Practices should coordinate with their organization’s contracting, finance, and quality teams to understand whether their TIN participates in an Advanced APM and how that participation affects individual clinicians.
Ambulatory specialty model (ASM)
CMS will launch the ASM on Jan. 1, 2027, as a mandatory Innovation Center model with five performance years through Dec. 31, 2031. It applies performance-based payment adjustments to selected specialists managing Original Medicare beneficiaries with heart failure or low back pain. CMS identifies participants at the TIN/NPI level in selected geographic areas, generally using a threshold of at least 20 attributed episodes.
- Current participants: The heart failure cohort includes cardiologists; the low back pain cohort includes anesthesiology, pain management, interventional pain management, neurosurgery, orthopedic surgery, and physical medicine and rehabilitation. CMS has posted the final 2027 participant list.
- Performance framework: The ASM evaluates quality, cost, improvement activities, and Promoting Interoperability. Quality and cost are generally assessed by TIN/NPI, although practices of 15 or fewer clinicians may report quality by group TIN. Improvement activities and Promoting Interoperability are reported at the group level and emphasize primary care collaboration, social-needs screening, and information exchange.
- Payment and MIPS interaction: The 2027 performance year determines the 2029 adjustment on Medicare Part B covered professional services. Adjustments range from -9% to +9% in the first two payment years and reach -12% to +12% by the final year. Required ASM participants are generally exempt from MIPS for the corresponding years, although ASM uses an MVP-like framework.
Impact on sleep medicine professionals and facilities
Sleep medicine is not a current ASM cohort, but the model may affect multispecialty organizations with cardiology, pain, surgical, or rehabilitation clinicians. Practices should check included clinicians against the CMS participant dataset and prepare for model-specific reporting rather than assuming ordinary MIPS requirements apply.
What sleep medicine practices should do now
For 2027, sleep medicine practices should focus on preparing for the continued transition toward MVP-based reporting, confirming that their existing quality measures remain available and applicable, evaluating the new core measure requirement, and assessing readiness for future electronic prior authorization and digital reporting requirements. Practices participating in multispecialty organizations should also determine whether clinicians within their TIN are subject to the ASM or Advanced APM arrangements that could change their reporting and payment pathway. Using 2027 as a preparation year can help practices reduce reporting disruptions and position themselves for the broader QPP changes expected later in the decade.
The full rule document and supporting QPP resources can be found below:
- Additional QPP resources are available in the QPP Resource Library
Members may send questions regarding changes to the Quality Payment Program to quality@aasm.org.
